Publications
- MxA mRNA decrease preceding NAb detection in IFN beta-treated MS patients2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus resistance protein A in interferon-β therapy in patients with multiple sclerosis and treatment effectiveness monitoring algorithm2016 | First Faculty of Medicine, Second Faculty of Medicine
- Monitoring of the Biological Effect of Interferon Beta in the Treatment of Multiple Sclerosis2013 | Second Faculty of Medicine
- Monitoring of interferon beta bioactivity in the multiple sclerosis2011 | Second Faculty of Medicine
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis2022 | Second Faculty of Medicine
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Elevated D-dimer as an immediate response to alemtuzumab treatment2021 | Second Faculty of Medicine
Loading network view...